结核分枝杆菌传统药敏试验方法.pptVIP

  1. 1、本文档共35页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
* This slide shows some of physicochemical factors affecting DST results. The amount of active drug in culture media may vary with drug dissolution, dilution, sterilization, and storage, and substantial amount of certain drugs added in the medium before inspissation or sterilization will be inactivated by heating and/or by protein binding or filtration. And some compounds in the media will antagonize activity of certain drugs. For example, phospholipids antagonize SM; D-alanine antagonize cycloserine; methionine antagonize PAS; polyamines or ions may antagonize EMB. Aminoglycisides and polypeptide antibiotics are fairly well sensitive to pH of medium. DST results are also influenced to a great extent by inoculum size, representativeness, dispersion and viability of bacilli in inoculum. So, if we fail control of those factors, we cannot obtain reliable and reproducible results. * * * * * * Objectives of this guideline is to assist TB control program managers and physicians in proper use of second-line drug susceptibility test data and to permit determination of true scope of second-line drug resistance for surveillance. The guideline also aim to recommend the laboratory to use standardized second-line DST methodologies and protocols; appropriate classes of drugs for DST; the scope of internal QC measures; and a framework for the evaluation of new drugs. * Objectives of this guideline is to assist TB control program managers and physicians in proper use of second-line drug susceptibility test data and to permit determination of true scope of second-line drug resistance for surveillance. The guideline also aim to recommend the laboratory to use standardized second-line DST methodologies and protocols; appropriate classes of drugs for DST; the scope of internal QC measures; and a framework for the evaluation of new drugs. 51个国家(或地区)参比实验室利福平和异烟肼药敏试验结果的一致性 (世界卫生组织第四期全球耐药报告,2008) % Agreement一致性 Isoniazid异烟肼 Rifampicin利福平 100 38 (77.6) 37 (72.5) 95-99 6 (12.2) 9 (17.6) 90

文档评论(0)

peace0308 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档